The depletion of NGF has been linked with neurodegenerative disorders such as Alzheimer’s disease2, while over expression of it is related with other diseases such as epilepsy3, glioma4, tumor metastasis5, 6 etc. Thus small-molecular neurotrophin agonist or antagonist is of high interest to promote or inhibit NGF activity. This evidence concerns the gene NGF and neoplasm.